April 24, 20244Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.
April 24, 20244Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
April 24, 20244Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.
Homepage North America North America Legal Chronicle Royalty Pharma’s $1.5 Billion Acquisition of PTC Therapeutics’ Royalties Royalty Pharma’s $1.5 Billion Acquisition of PTC Therapeutics’ Royalties October 30, 2023 Leila Ahmed Tagged: 10-30-2023 Barry Bazian Carl Morales Catherine Magazu Elliot Horlick Emily Powers Fenwick & West LLP George Shuster Jr Goodwin Procter Jacqueline Mercier Kristopher Ring megadeals Nathan Moore PTC Therapeutics Robert Crawford Royalty Pharma William Ogden Wilmer Cutler Pickering Hale and Dorr Zhe Yang Fenwick & West, Goodwin Procter and Maiwald represented Royalty Pharma in the transaction, Wilmer Cutler Pickering Hale and Dorr represented PTC Therapeutics.Royalty Pharma plc (Nasdaq: RPRX)… This content is for Standard 1 Year members only.Login Join Now